Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which is known to exert death-inducing as well as nonapoptotic functions, has been shown to be expressed by the early trophoblast. Here we report that TRAIL has no apoptotic effects on human endometrial stromal cells, but differentially regulates cytokines and chemokines and might therefore play a role in the modulation of the cytokine milieu at the implantation site.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Apoptosis / drug effects*
-
Cell Differentiation / drug effects
-
Cells, Cultured
-
Chemokine CCL2 / metabolism*
-
Decidua / drug effects
-
Decidua / metabolism
-
Embryo Implantation / drug effects
-
Endometrium / drug effects*
-
Endometrium / metabolism
-
Endometrium / physiology
-
Female
-
Humans
-
Interleukin-6 / metabolism*
-
Interleukin-8 / metabolism*
-
Leukemia Inhibitory Factor / metabolism*
-
Receptors, TNF-Related Apoptosis-Inducing Ligand / metabolism
-
Recombinant Proteins / pharmacology
-
Stromal Cells / drug effects
-
Stromal Cells / metabolism
-
Stromal Cells / physiology
-
TNF-Related Apoptosis-Inducing Ligand / metabolism
-
TNF-Related Apoptosis-Inducing Ligand / pharmacology*
-
TNF-Related Apoptosis-Inducing Ligand / physiology
Substances
-
Chemokine CCL2
-
Interleukin-6
-
Interleukin-8
-
LIF protein, human
-
Leukemia Inhibitory Factor
-
Receptors, TNF-Related Apoptosis-Inducing Ligand
-
Recombinant Proteins
-
TNF-Related Apoptosis-Inducing Ligand